Neurobiology of Aging
Volume 31, Issue 4 , Pages 605-613 , April 2010

Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice

  • Amy S. Nakashima

      Affiliations

    • Department of Psychology, University of Calgary, 2500 University Drive, NW, Calgary, Alberta, Canada T2N 1N4
    • ,
  • Salvatore Oddo

      Affiliations

    • Department of Neurobiology and Behavior, University of California, Irvine, CA 92697-4545, USA
    • ,
  • Frank M. LaFerla

      Affiliations

    • Department of Neurobiology and Behavior, University of California, Irvine, CA 92697-4545, USA
    • ,
  • Richard H. Dyck

      Affiliations

    • Department of Psychology, University of Calgary, 2500 University Drive, NW, Calgary, Alberta, Canada T2N 1N4
    • Department of Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, 3300 Hospital Drive, NW, Calgary, Alberta, Canada T2N 4N1
    • Corresponding Author InformationCorresponding author at: Department of Psychology, University of Calgary, 2500 University Drive, NW, Calgary, Alberta, Canada T2N 1N4. Tel.: +1 403 220 4206; fax: +1 403 282 8249.

Received 29 March 2008 ,Revised 8 May 2008 ,Accepted 18 May 2008.

References 

  1. Assaf SY, Chung SH. Release of endogenous Zn2+from brain tissue during activity. Nature. 1984;308(5961):734–736
  2. Barnes LL, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Gender, cognitive decline, and risk of AD in older persons. Neurology. 2003;60(11):1777–1781
  3. Beaulieu C, Dyck R, Cynader M. Enrichment of glutamate in zinc-containing terminals of the cat visual cortex. Neuroreport. 1992;3(10):861–864
  4. Beltramini M, Zambenedetti P, Wittkowski W, Zatta P. Effects of steroid hormones on the Zn, Cu and MTI/II levels in the mouse brain. Brain Res. 2004;1013(1):134–141
  5. Brown CE, Dyck RH. Rapid experience-dependent changes in levels of synaptic zinc in primary somatosensory cortex of the adult mouse. J. Neurosci. 2002;22(7):2617–2625
  6. Brown CE, Dyck RH. Experience-dependent regulation of synaptic zinc is impaired in the cortex of aged mice. Neuroscience. 2003;119(3):795–801
  7. Brown CE, Dyck RH. Modulation of synaptic zinc in barrel cortex by whisker stimulation. Neuroscience. 2005;134(2):355–359
  8. Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (New York, NY). 1994;265(5177):1464–1467
  9. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am. J. Pathol. 2001;158(3):1173–1177
  10. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007;27(48):13357–13365
  11. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 2001;30(3):665–676
  12. Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S, et al. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol. Dis. 2007;
  13. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, et al. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J. Biol. Chem. 2000;275(26):19439–19442
  14. Czupryn A, Skangiel-Kramska J. Differential response of synaptic zinc levels to sensory deprivation in the barrel cortex of young and adult mice. Exp. Brain Res. 2001;141(4):567–572
  15. Danscher G. Exogenous selenium in the brain. A histochemical technique for light and electron microscopical localization of catalytic selenium bonds. Histochemistry. 1982;76(3):281–293
  16. Esler WP, Stimson ER, Jennings JM, Ghilardi JR, Mantyh PW, Maggio JE. Zinc-induced aggregation of human and rat beta-amyloid peptides in vitro. J. Neurochem. 1996;66(2):723–732
  17. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291(24):2959–2968
  18. Felicio LS, Nelson JF, Finch CE. Longitudinal studies of estrous cyclicity in aging C57BL/6J mice. II. Cessation of cyclicity and the duration of persistent vaginal cornification. Biol. Reprod. 1984;31(3):446–453
  19. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology. 1986;11(3):337–345
  20. Frederickson CJ. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 1989;31:145–238
  21. Gouras GK, Xu H, Gross RS, Greenfield JP, Hai B, Wang R, et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc. Natl. Acad. Sci. U.S.A. 2000;97(3):1202–1205
  22. Harley CW, Malsbury CW, Squires A, Brown RA. Testosterone decreases CA1 plasticity in vivo in gonadectomized male rats. Hippocampus. 2000;10(6):693–697
  23. Henderson VW, Hogervorst E. Testosterone and Alzheimer disease: is it men's turn now?. Neurology. 2004;62(2):170–171
  24. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000;54(2):295–301
  25. Howell GA, Welch MG, Frederickson CJ. Stimulation-induced uptake and release of zinc in hippocampal slices. Nature. 1984;308(5961):736–738
  26. Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, et al. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res. 2004;1017(1/2):130–136
  27. Huang X, Atwood CS, Moir RD, Hartshorn MA, Vonsattel JP, Tanzi RE, et al. Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 1997;272(42):26464–26470
  28. Izumi Y, Auberson YP, Zorumski CF. Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J. Neurosci. 2006;26(27):7181–7188
  29. Katzman R, Aronson M, Fuld P, Kawas C, Brown T, Morgenstern H, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann. Neurol. 1989;25(4):317–324
  30. Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 2005;11(5):556–561
  31. Kodirov SA, Takizawa S, Joseph J, Kandel ER, Shumyatsky GP, Bolshakov VY. Synaptically released zinc gates long-term potentiation in fear conditioning pathways. Proc. Natl. Acad. Sci. U.S.A. 2006;
  32. Lee JY, Mook-Jung I, Koh JY. Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice. J. Neurosci. 1999;19(11):RC10
  33. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2002;99:7705–7710
  34. Lee JY, Kim JH, Hong SH, Cherny RA, Bush AI, Palmiter RD, et al. Estrogen decreases zinc transporter 3 expression and synaptic vesicle zinc levels in mouse brain. J. Biol. Chem. 2004;279(10):8602–8607
  35. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (New York, NY). 2001;293(5534):1487–1491
  36. Li Y, Hough CJ, Frederickson CJ, Sarvey JM. Induction of mossy fiber -->Ca3 long-term potentiation requires translocation of synaptically released Zn2+. J. Neurosci. 2001;21(20):8015–8025
  37. Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, Li QX, et al. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. J. Inorg. Biochem. 2006;100(5/6):952–962
  38. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–193
  39. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial Alzheimer's Disease Cooperative Study. JAMA. 2000;283(8):1007–1015
  40. Nelson JF, Karelus K, Felicio LS, Johnson TE. Genetic influences on the timing of puberty in mice. Biol. Reprod. 1990;42(4):649–655
  41. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging. 2003;24(8):1063–1070
  42. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39(3):409–421
  43. Paoletti AM, Congia S, Lello S, Tedde D, Orru M, Pistis M, et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004;62(2):301–303
  44. Religa D, Strozyk D, Cherny RA, Volitakis I, Haroutunian V, Winblad B, et al. Elevated cortical zinc in Alzheimer disease. Neurology. 2006;67(1):69–75
  45. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 2003;60(12):1685–1691
  46. Rocca WA, Amaducci LA, Schoenberg BS. Epidemiology of clinically diagnosed Alzheimer's disease. Ann. Neurol. 1986;19(5):415–424
  47. Rosario ER, Pike CJ. Androgen regulation of B-amyloid and the risk of Alzheimer's disease. Brain Res. Rev. 2007;
  48. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J. Neurosci. 2006;26(51):13384–13389
  49. Rowan MJ, Klyubin I, Wang Q, Anwyl R. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity. Exp. Gerontol. 2004;39(11/12):1661–1667
  50. Rowan MJ, Klyubin I, Wang Q, Anwyl R. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochem. Soc. Trans. 2005;33:563–567(Pt 4)
  51. Sandberg G, Stewart W, Smialek J, Troncoso JC. The prevalence of the neuropathological lesions of Alzheimer's disease is independent of race and gender. Neurobiol. Aging. 2001;22(2):169–175
  52. Sensi SL, Rapposelli IG, Frazzini V, Mascetra N. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp. Gerontol. 2007;
  53. Shiroma S, Yamaguchi T, Kometani K. Effects of 17beta-estradiol on chemically induced long-term depression. Neuropharmacology. 2005;49(1):97–102
  54. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–2662
  55. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947–2958
  56. Smith CC, McMahon LL. Estrogen-induced increase in the magnitude of long-term potentiation occurs only when the ratio of NMDA transmission to AMPA transmission is increased. J. Neurosci. 2005;25(34):7780–7791
  57. Smith CC, McMahon LL. Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors. J. Neurosci. 2006;26(33):8517–8522
  58. Smith MD, Jones LS, Wilson MA. Sex differences in hippocampal slice excitability: role of testosterone. Neuroscience. 2002;109(3):517–530
  59. Suh SW, Jensen KB, Jensen MS, Silva DS, Kesslak PJ, Danscher G, et al. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 2000;852(2):274–278
  60. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348(9025):429–432
  61. Vouimba RM, Foy MR, Foy JG, Thompson RF. 17Beta-estradiol suppresses expression of long-term depression in aged rats. Brain Res. Bull. 2000;53(6):783–787
  62. Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology. 2000;54(11):2061–2066
  63. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol. Dis. 2003;14(3):318–327

PII: S0197-4580(08)00174-7

doi: 10.1016/j.neurobiolaging.2008.05.028

Neurobiology of Aging
Volume 31, Issue 4 , Pages 605-613 , April 2010

Article Tools

* Image Usage & Resolution